Canadian Journal of Infectious Diseases and Medical Microbiology

Canadian Journal of Infectious Diseases and Medical Microbiology / 2020 / Article

Research Article | Open Access

Volume 2020 |Article ID 3509676 |

Jennifer O. Adeghate, Emese Juhász, Miklós Á. Iván, Júlia Pongrácz, Katalin Kristóf, "Similar Strains of Coagulase-Negative Staphylococci Found in the Gastrointestinal Tract and Bloodstream of Bacteremic Neonates", Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 2020, Article ID 3509676, 9 pages, 2020.

Similar Strains of Coagulase-Negative Staphylococci Found in the Gastrointestinal Tract and Bloodstream of Bacteremic Neonates

Academic Editor: Pascal Thibon
Received08 Dec 2019
Revised24 Mar 2020
Accepted05 May 2020
Published21 Jul 2020


Objectives. Premature neonates are susceptible to opportunistic and nosocomial infections. Efforts have been made to determine whether the neonatal gut microbiome possesses potential for causing bloodstream infections in newborns via microbial translocation from the gastrointestinal tract. We aimed to examine similarities in coagulase-negative staphylococci (CoNS) strains found in the gastrointestinal tract and bloodstream in bacteremic neonates. Methods. CoNS strains isolated from blood cultures and perianal and pharyngeal swab samples of neonates from two neonatal intensive care units were investigated using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and pulsed-field gel electrophoresis. Molecular mass and genetic similarities of CoNS strains were compared. Results. Marked similarity was found in the molecular mass and genetic profile of examined CoNS isolates from blood cultures and perianal/pharyngeal samples. The percentage of neonates developing bacteremia following perianal and pharyngeal colonization by CoNS was significantly higher when compared to those colonized by Enterobacteriales species (). Conclusions. CoNS colonizing the gut may be a source of bacteremia in neonates. Enterobacteriales species do not contribute as significantly to bacteremia when compared to CoNS, and may be protective against gut mucosa-originated systemic infection.

1. Introduction

Premature neonates are a patient population that is susceptible to opportunistic and nosocomial infections, particularly in the setting of their undeveloped immune systems [1]. Both full-term and premature neonates treated in neonatal intensive care units (NICU) are at a high risk of acquiring invasive infections due to their need for a complex level of care [2]. Over the past few years, more emphasis has been placed on discovering the components of the neonatal gut microbiota [3, 4], in search of a better understanding of the development of bloodstream infections (BSIs) in this patient population.

Several factors are involved in the gut colonization process including (a) the mode of delivery of the neonate, (b) the type of nutrition administered after birth, and (c) whether or not the neonate has been exposed to larger doses of antimicrobial drugs [5]. The first set of microorganisms to colonize the gastrointestinal (GI) tract will eventually determine the features of the gut microbiota later in life. If the original microbiota does not develop the necessary components or does not develop at the right pace—a process called “dysbiosis” [6]—then this will affect the neonate later on by increasing the likelihood of developing various autoimmune or atopic diseases, such as asthma and other allergic conditions [7]. Additionally, the overuse of antibiotics kills the bacteria that would otherwise colonize and protect the GI tract, leaving the gut of the neonate less populated by protective bacteria in a form of the so-called “hygiene hypothesis” [8]. Other conditions that may develop later in life include Crohn’s disease in neonates with extreme antibiotic exposure [9] and celiac disease in neonates delivered via Cesarean section [10].

Studies have shown that the GALT (gut-associated lymphoid tissue) is gradually desensitized to microorganisms within the gut due to crosstalk between the GALT and the mucosa [7, 11]. Weng et al. showed that this is an inflammatory process initiated by colonizing bacteria, which produces signals that activate the GALT and the immune system. Stimuli include reactive oxygen species and pathogen-associated molecular patterns [6, 7]. These communications allow for the gut to develop tolerance to the colonizing gut microbiota and to alimentary antigens [6]. The process by which the GI tract develops tolerance to the colonizing commensal gut microbiota is thought to occur via production of IgA immunoglobulins against their antigens [12]. This process is complemented by IgA immunoglobulins obtained exogenously from breast milk [13, 14].

Obligate anaerobes have been shown to play an important role in the protection of the GI mucosa; therefore, their absence in the premature gut poses a great threat to its integrity by decreasing the effectiveness of the epithelial barrier [15, 16]. This causes the otherwise harmless colonizing microbiota of the GI tract, or in some cases pathogenic microorganisms acquired from the environment, to translocate through the mucosa, reach the blood vessels within the intestinal wall, and disseminate throughout the body [17]. In healthy, developed infants, the likelihood of bacteremia arising after such processes is low due to sufficient eradication of the microorganisms by cellular and humoral mechanisms of the immune system. However, since immunity to infection is low in premature neonates, manifest septic states can occur more easily.

Bloodstream infections (BSIs) are the most common form of nosocomial disease in all neonates [18]. In general, BSIs are becoming more prevalent due to the increased use of invasive medical devices and the overall lengthening of hospital stays. Because of these factors, neonates treated in the ICU setting are particularly susceptible to acquiring nosocomial infections. As such, the length of hospitalization has been shown to correlate with the prevalence of late-onset BSIs in very-low birth weight neonates [19, 20]. It has been shown that almost 40% of all neonates, both full-term and premature, being treated in the NICU will contract a nosocomial infection [21]. This number is much higher (67%) in developing countries due to differences in the standards of healthcare, such as hygiene regulations and practices [22]. The mortality rate in neonates affected by invasive nosocomial infections depends highly on gestational age and weight, length of hospital stay, and the type of pathogen involved in a bloodstream infection. Early-onset BSIs are known to have a higher mortality rate than late-onset BSIs due to the involvement and ultimate failure of multiple organs [23].

Most coagulase-negative staphylococci (CoNS) are found on the skin and mucosal surfaces, and are implicated in a variety of opportunistic and nosocomial infections, with S. epidermidis being the most common (about 70–80% of infections) [24]. CoNS possess a strong potential for causing invasive BSIs in newborns, especially in those born prematurely. They have been shown to be the most common cause of bacteremia in neonates, causing more than 50% of bloodstream infections (BSIs) in this group of patients [2527]. This was also shown by Shivanna et al. [28], where 66% of isolates from positive blood cultures of neonates with BSIs were CoNS. Mortality due to suspected BSI caused by CoNS has been shown to occur in up to 10% of neonates treated in the NICU [29, 30]. The process of BSIs is thought to be associated with translocation of these microorganisms from the gastrointestinal (GI) tract into the bloodstream [24]. However, there is still scarce evidence as to whether the gut-colonizing CoNS may be involved directly in bloodstream infections by bypassing the mucosal immune system and entering the circulation. The most definitive and effective method for detecting CoNS bacteremia is by blood culture [2]. Surveillance samples are used to compare the strains isolated from invasive samples to those residing in various organ systems [31]. This method of identification is widely used in NICUs in order to monitor the composition of the commensal gut microbiota.

Virulence factors associated with CoNS are involved mainly in the formation of biofilms around their colonies on the surface of inanimate objects such as intravenous catheters and endotracheal tubes [32]. Within this biofilm layer, they are unreachable to the components of the cellular or humoral immune system, as well as to antibiotics [3335], preventing them from being eliminated from the surfaces they are attached to [36]. They also produce various extracellular enzymes, including oxidases, hyaluronidases, lipases, hemolysins, and proteases, which protect them and aid in multiplication and survival. The severity of a CoNS infection depends highly on the virulence of the infectious strains [37], though in general, this group causes milder symptoms than coagulase-positive staphylococci such as Staphylococcus aureus. Also, when affecting neonates, prematurity is a significant risk factor in the development and progression of CoNS-related BSIs, with full-term neonates being more tolerant and resistant to major manifestations of these infections [37].

Coagulase-negative staphylococci have also been isolated from the stool of neonates with BSIs in a gene sequencing study completed by Madan et al. [38], showing that CoNS may in fact be predominantly present in the GI tract of premature neonates and may have a role in the development of sepsis. Although extensive research has been performed on the development of sepsis due to the translocation of Gram-negative bacteria from the gut into the bloodstream [3941], more evidence is required to prove that CoNS could follow this route of infection as well.

Our aim was to determine whether CoNS strains colonizing the gut were related to strains isolated from blood cultures in bacteremic neonates. Further aims of this study were to analyze whether or not bloodstream infections occurring in the neonatal patient population could have been associated with resident gut bacteria and to determine the extent of protection that the resident gut bacteria provides when facing BSIs. This may provide further insight into whether CoNS colonizing the GI tract mucosa may be involved in systemic infection.

2. Materials and Methods

Our study included a three-year (January 2013 to December 2015) retrospective analysis of 1118 neonates hospitalized in the NICUs of two large university teaching hospitals in Budapest, Hungary. The microbiological results of clinical samples, such as blood cultures and peritoneal fluid samples (invasive sampling), and perianal and pharyngeal swab samples (surveillance sampling), were examined. From these 1118 neonates, a total of 5093 perianal samples (average 4.6 samples per neonate), 4022 pharyngeal surveillance samples (average 3.6 samples per neonate), and 4294 blood cultures (average 3.8 samples per neonate) were obtained. Of the 4294 blood cultures obtained, 588 blood cultures were positive for microorganisms. Of these, 449 blood cultures were positive for CoNS and 45 for Enterobacteriales species; however, only 390 CoNS-positive and 43 Enterobacteriales species-positive blood cultures had concurrent surveillance samples (perianal and pharyngeal swabs) obtained for genetic analysis and comparison of strains. Multiple samples were taken per neonate, as they were followed over time during the course of their suspected infection. Samples may also have been insufficient or contaminated and therefore had to be repeated. Since multiple surveillance samples and blood cultures were collected from each newborn, the results were depicted by sample, not by the number of neonates. Our prospective analysis of species identification and antibiotic susceptibility testing were performed on each blood culture isolate, but perianal and pharyngeal isolates were identified only as CoNS or Enterobacteriales. Bacteria cultured from perianal swab samples were accepted as representative for predominant gut-colonizing bacteria.

Neonates whose blood cultures were positive for either of the two most significant neonatal CoNS pathogens (S. epidermidis and S. haemolyticus) were further investigated. In a prospective ten-month period (September 2015 to June 2016), S. epidermidis and S. haemolyticus isolates cultured from both invasive and surveillance samples were collected and stored in glycerol-supplemented broth at −20°C for later use. Only perianal and pharyngeal isolates that were collected during this ten-month period were identified at species levels. Otherwise, perianal and pharyngeal isolates were identified as CoNS or Enterobacteriales and further protein mass spectrometry and genetic analysis were not performed. The genetic diversity of these isolates was compared using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and pulsed-field gel electrophoresis (PFGE).

MALDI-TOF MS analysis (Bruker, Daltonik GmbH, Fahrenheitstraße 4, Bremen, Germany) was used to identify bacteria during the routine diagnostic process. To reveal potential relatedness of bacterial isolates from different samples, MALDI-TOF MS analysis was performed on five S. epidermis and seven S. haemolyticus isolates selected at random from CoNS-positive surveillance and blood culture samples of two affected neonates. The direct smear method was used. Bacterial smears were pretreated with 70% formic acid and then overlaid by alpha-cyano-4-hydroxycinnamic acid matrix substance. The molecular mass of the proteins was compared based on spectrometric results using the FlexAnalysis program (Bruker). The mass spectrum of the proteins was subtracted from the baseline and smoothed once before analysis. The analysis was performed according to the Bruker FlexControl program. Although MALDI-TOF MS is an accepted form of relatedness testing, a more standardized method was required to characterize and compare the different isolates in this study. Therefore, we used PFGE to determine the genetic relativity of the isolates.

The genetic profiles of the previously described five S. epidermidis and seven S. haemolyticus isolates were obtained after SmaI DNA digestion. These were compared to the patterns from random control samples in order to confirm validity of the PFGE results. Pulsed-field gel electrophoresis was conducted based on a departmental protocol modified for CoNS [42]. All strains were grown overnight on blood agar plates at 37°C, and DNA was released from the cells using lysostaphin (Sigma, St. Louis, Missouri, USA). DNA was digested with SmaI (Promega, Madison, Wisconsin, USA) at 25°C for 3 hours. Gel electrophoresis was then performed in 1% agarose gel (Bio-Rad, Hercules, California, USA) using the CHEF-DR-II apparatus (Bio-Rad) in TBE buffer (1x Tris-borate-EDTA, pH: 8.3; Bio-Rad). Lambda DNA PFGE Marker (BioLabs, Budapest, Hungary) was used as a size standard in the first lane on each gel. Electrophoresis conditions were 14°C for 21 hours, with pulse time ranging from 5 to 60 seconds at an angle of 120°. Voltage was 6 V/cm. Gels were stained with ethidium bromide solution (Sigma) and digitalized with UVItec (Pharmacia Biotech, Piscataway, New Jersey, USA). The DNA band patterns obtained were analyzed visually with Diversity Database software, version 2.2.0 (Bio-Rad). Dendrograms were created using UPGMA clustering of a similarity matrix based on band-matching Dice coefficients (tolerance 1%, optimization 1%). Isolates showing indistinguishable or closely related band patterns (≤6 band differences, >8% similarity) were regarded as likely to be clonally related, as suggested by Tenover et al. [43].

3. Results

3.1. Bacterial Components of Perianal, Pharyngeal, and Blood Culture Samples

CoNS were isolated from 1885 (37%) of the perianal samples and 1619 (40.3%) of the pharyngeal samples. Enterobacteriales species were isolated from 1743 (34.2%) perianal samples and 559 (13.9%) pharyngeal samples (Figure 1). Of the neonates whose perianal and pharyngeal samples were positive for CoNS and Enterobacteriales species, the number of blood cultures positive for the same microbes was also determined. Of the neonates whose perianal samples were CoNS-positive (n = 1885), 216 blood cultures were also found to be positive for CoNS (11.5%). Meanwhile, of the neonates with CoNS-positive pharyngeal samples (n = 1619), 174 blood cultures were positive for CoNS (10.7%). Similarly, in the cohort with 1743 Enterobacteriales species-positive perianal samples, 34 (2.0%) blood cultures were also positive for Enterobacteriales species. In addition, out of 559 Enterobacteriales species-positive pharyngeal samples, 9 (1.6%) blood cultures were positive for Enterobacteriales species. The percentage distribution of neonates who acquired bacteremia following colonization by CoNS was markedly higher compared to bacteremia after colonization by Enterobacteriales species () (Table 1).

YearType of culture (CoNS)CoNS bacteremia (%)Enterobacterial bacteremia (%)Type of culture (Enterobacteria)

2013Perianal (n = 608)7.91.1Perianal (n = 379)
Pharyngeal (n = 475)8.20.0Pharyngeal (n = 125)
2014Perianal (n = 635)11.01.8Perianal (n = 501)
Pharyngeal (n = 548)10.00.0Pharyngeal (n = 145)
2015Perianal (n = 642)15.32.4Perianal (n = 863)
Pharyngeal (n = 596)13.43.1Pharyngeal (n = 289)
Total perianal: 188534.25.3Total perianal: 1743
Total pharyngeal: 161931.63.1Total pharyngeal: 559

3.2. Distribution of Pathogens in All Positive Blood Cultures

There were a total of 588 blood cultures positive for microorganisms. Of these, 76.4% (n = 449) of isolates were CoNS species. The distribution of these species was as follows: S. epidermidis (n = 245; 54.6%), S. haemolyticus (n = 104, 23.2%), S. hominis (n = 64; 14.3%), S. warneri (n = 11; 2.4%), and S. capitis (n = 6; 1.3%). Other strains made up the remaining 4.2% (n = 19) (Figure 2(a)). Enterobacteriales species made up 7.7% (n = 45) of strains isolated from the 588 positive blood cultures. The majority of bacteria that comprised this group were Klebsiella pneumoniae (n = 23; 51.1%) and Escherichia coli (n = 16; 35.6%) strains. Others include Enterobacter cloacae (n = 3; 6.7%), Klebsiella oxytoca (n = 1; 2.2%), Pantoea agglomerans (n = 1; 2.2%), and Pantoea calida (n = 1, 2.2%) (Figure 2(b)).

3.3. Characterization of Pathogens by MALDI-TOF MS and PFGE

MALDI-TOF MS analysis, including dendrograms of CoNS strains isolated from positive blood cultures, showed marked similarity to the strains isolated from the surveillance samples (Figures 3(a)3(d)). The molecular mass of proteins belonging to S. epidermidis and S. haemolyticus strains isolated from blood cultures showed notable resemblance to the proteins of strains isolated from pharyngeal and perianal samples. The strains causing bacteremia had molecular masses that were different from those belonging to strains isolated from a healthy neonate (Figure 3(e)), indicating a possible difference in virulence between pathogenic and nonpathogenic strains of colonizing CoNS.

The PFGE dendrogram and patterns of tested isolates are shown in Figure 4. Five S. epidermidis strains isolated from pharyngeal and perianal samples from a bacteremic neonate appeared to have a different genetic profile compared to that isolated from blood culture. Four S. epidermidis strains from four healthy neonates were used as controls. On the other hand, seven S. haemolyticus strains from pharyngeal, perianal, and blood culture samples from another bacteremic neonate appeared to have an identical genetic profile. Four S. haemolyticus strains from four healthy neonates were used as controls. Isolates from the healthy neonates were similar, but not identical. The dendrograms resulting from the PFGE and MALDI-TOF MS analysis showed marked resemblance.

4. Discussion

In our study, CoNS and Enterobacteriales strains isolated from blood and surveillance cultures of 1118 neonates were analyzed, and selected CoNS isolates were compared using MALDI-TOF MS and PFGE.

Several studies have shown the involvement of CoNS in the development of neonatal sepsis, as newborns treated in the NICU are frequently subjected to invasive and semi-invasive procedures that have a high potential for introducing bacteria into the bloodstream [28]. Coagulase-negative staphylococci comprised over 75% of microorganisms isolated from positive blood cultures in the neonates examined in our study, which corroborates with that of multiple studies which have shown that 50–66% of isolates from bacteremic neonates’ blood cultures were CoNS [2528].

Despite extensive research on the pathomechanisms by which GI-colonizing bacteria may cause systemic infection via translocation through the GI mucosa, the role of CoNS in this process, as a component of the gut microbiota, is unclear. We observed that despite the large number of enterobacteria colonizing the GI tract, only a small percentage of these microorganisms caused BSIs (1.6–2.0%) in the studied neonates, whereas among the CoNS-colonized neonates, 10.7–11.5% of CoNS caused blood stream infections. This implies that the infectivity of CoNS had surpassed that of other colonizing microbes such as Enterobacteriales species. Whether or not the source of CoNS bacteremia was the colonized gut mucosa raises the point that more attention should be paid to bacteremia caused by CoNS in previously CoNS-colonized neonates. Additional virulence testing would be helpful in determining whether specific strains of gut-colonizing CoNS are more likely than others to cause BSIs during the perinatal period. Further research is need to elucidate the combination of host factors and CoNS virulence factors that together could result in systemic infection from the naturally colonized gut mucosa. Especially in terms of prevention, further investigations are essential.

The molecular mass of proteins of S. epidermidis and S. haemolyticus strains isolated from selected neonates’ blood cultures showed marked similarity to those isolated from the same neonates’ perianal and pharyngeal samples. Moreover, the genetic makeup of S. haemolyticus strains of a symptomatic neonate showed identical PFGE genotypes. We also observed that the molecular mass and genome of these isolates in symptomatic neonates were different from those isolated from healthy neonates. This indicates that the molecular mass and genome of S. epidermidis and S. haemolyticus isolates from symptomatic neonates belonged to one genetic variant, while those obtained from the healthy neonate belonged to another. This may imply that isolates from respective invasive and surveillance samples were genetically related to each other in bacteremic neonates. It is also possible that the strains causing invasive infection may be from the same genetic variant indicating possible affinity for colonizing strains to cause systemic infection. More research is required in order to determine causality in these cases.

Our results showed that there was a much larger incidence of bacteremia in neonates whose GI tract was colonized by CoNS alone than in those colonized by Enterobacteriales species. The CoNS isolates representative for gut-colonizing bacteria matched the isolates cultured from blood samples, indicating that the bacteremia could have originated from the gut mucosa. This could indicate that either CoNS has a greater potential for becoming invasive from a colonizer state, or that the predominantly enterobacterial gut colonization plays more of a protective than infective role. In fact, it has been shown that the gut microbiota may indeed play a protective role in the maintenance of GI homeostasis [44].

Due to the severe consequences of bloodstream infections and an increase in antibiotic resistance [45], further insight into their pathogenesis should be sought in order to establish and implement preventive measures against systemic infection, particularly in the case of seemingly harmless colonizing CoNS.

Data Availability

The clinical data used to support the findings of this study are included within the article. Deidentified raw data used to support the findings of this study are available from the corresponding author upon request.

Ethical Approval

The Institute of Laboratory Medicine reviewed and approved the use of laboratory and patient data for the purpose of this study, and all research was conducted in accordance with the Declaration of Helsinki.

Conflicts of Interest

The authors declare that they have no conflicts of interest.


The authors would like to thank all the staff at the Institute of Laboratory Medicine including Professor Barna Vásárhelyi and Natasa Pesti for their help and support. This study was supported by the Institute of Laboratory Medicine at Semmelweis University, Budapest, Hungary.


  1. O. Levy, “Innate immunity of the newborn: basic mechanisms and clinical correlates,” Nature Reviews Immunology, vol. 7, no. 5, pp. 379–390, 2007. View at: Publisher Site | Google Scholar
  2. K. Kristóf, E. Kocsis, and K. Nagy, “Clinical microbiology of early-onset and late-onset neonatal sepsis, particularly among preterm babies,” Acta Microbiologica et Immunologica Hungarica, vol. 56, no. 1, pp. 21–51, 2009. View at: Publisher Site | Google Scholar
  3. K. Le Doare, B. Holder, A. Bassett, and P. S. Pannaraj, “Mother’s milk: a purposeful contribution to the development of the infant microbiota and immunity,” Frontiers in Immunology, vol. 9, p. 361, 2018. View at: Publisher Site | Google Scholar
  4. C. Milani, S. Duranti, F. Bottacini et al., “The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota,” Microbiology and Molecular Biology Reviews, vol. 81, no. 4, Article ID e00036, p. 17, 2017. View at: Publisher Site | Google Scholar
  5. B. Brooks, R. S. Mueller, J. C. Young, M. J. Morowitz, R. L. Hettich, and J F. Banfield, “Strain-resolved microbial community proteomics reveals simultaneous aerobic and anaerobic function during gastrointestinal tract colonization of a preterm infant,” Frontiers in Microbiology, vol. 6, p. 654, 2015. View at: Publisher Site | Google Scholar
  6. M. W. Groer, A. A. Luciano, L. J. Dishaw, T. L. Ashmeade, E. Miller, and J. A. Gilbert, “Development of the preterm infant gut microbiome: a research priority,” Microbiome, vol. 2, no. 1, p. 38, 2014. View at: Publisher Site | Google Scholar
  7. M. Weng and W. A. Walker, “The role of gut microbiota in programming the immune phenotype,” Journal of Developmental Origins of Health and Disease, vol. 4, no. 3, pp. 203–214, 2013. View at: Publisher Site | Google Scholar
  8. W. Murk, K. R. Risnes, and M. B. Bracken, “Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review,” Pediatrics, vol. 127, no. 6, pp. 1125–1138, 2011. View at: Publisher Site | Google Scholar
  9. A. Hviid, H. Svanstrom, and M. Frisch, “Antibiotic use and inflammatory bowel diseases in childhood,” Gut, vol. 60, no. 1, pp. 49–54, 2011. View at: Publisher Site | Google Scholar
  10. M. Eggesbo, G. Botten, H. Stigum, P. Nafstad, and P. Magnus, “Is delivery by cesarean section a risk factor for food allergy?” Journal of Allergy and Clinical Immunology, vol. 112, no. 2, pp. 420–426, 2003. View at: Google Scholar
  11. S. Salminen, C. Bouley, M. C. Boutron et al., “Functional food science and gastrointestinal physiology and function,” British Journal of Nutrition, vol. 80, no. S1, pp. S147–S171, 1998. View at: Publisher Site | Google Scholar
  12. L. V. Hooper, D. R. Littman, and A. J. Macpherson, “Interactions between the microbiota and the immune system,” Science, vol. 336, no. 6086, pp. 1268–1273, 2012. View at: Publisher Site | Google Scholar
  13. B. Corthésy, “Multi-faceted functions of secretory IgA at mucosal surfaces,” Frontiers in Microbiology, vol. 4, p. 185, 2013. View at: Publisher Site | Google Scholar
  14. E. W. Rogier, A. L. Frantz, M. E. C. Bruno et al., “Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression,” Proceedings of the National Academy of Sciences, vol. 111, no. 8, pp. 3074–3079, 2014. View at: Publisher Site | Google Scholar
  15. J. B. Ewaschuk, H. Diaz, L. Meddings et al., “Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 295, no. 5, pp. G1025–G1034, 2008. View at: Publisher Site | Google Scholar
  16. H. Qin, Z. Zhang, X. Hang, and Y. Jiang, “L. plantarum prevents Enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells,” BMC Microbiology, vol. 9, no. 1, p. 63, 2009. View at: Publisher Site | Google Scholar
  17. L. C. Duffy, “Interactions mediating bacterial translocation in the immature intestine,” The Journal of Nutrition, vol. 130, no. 2, pp. 432S–436S, 2000. View at: Publisher Site | Google Scholar
  18. J. Raymond and Y. Aujard, “Nosocomial infections in pediatric patients: a European, multicenter prospective study,” Infection Control and Hospital Epidemiology, vol. 21, no. 4, pp. 260–263, 2000. View at: Publisher Site | Google Scholar
  19. A. Chmielarczyk, M. Pobiega, J. Wójkowska-Mach, D. Romaniszyn, P. B. Heczko, and M. Bulanda, “Bloodstream infections due to enterobacteriaceae among neonates in Poland - molecular analysis of the isolates,” Polish Journal of Microbiology, vol. 64, no. 3, pp. 217–225, 2015. View at: Publisher Site | Google Scholar
  20. B. J. Stoll, T. Gordon, S. B. Korones et al., “Late-onset sepsis in very low birth weight neonates: a report from the national Institute of child health and human development neonatal research network,” The Journal of Pediatrics, vol. 129, no. 1, pp. 63–71, 1996. View at: Publisher Site | Google Scholar
  21. R. C. Couto, E. A. A. Carvalho, T. M. G. Pedrosa, Ê. R. Pedrosa, M. C. Neto, and F. M. Biscione, “A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units,” American Journal of Infection Control, vol. 35, no. 3, pp. 183–189, 2007. View at: Publisher Site | Google Scholar
  22. M. M. Omar, Nosocomial Infections in Kasr El Aini Neonatal Intensive Care Unit (NICU) as a University Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt, 2001, M.S. thesis.
  23. I. R. Makhoul, P. Sujov, T. Smolkin, A. Lusky, B. Reichman, and Israel Neonatal Network, “Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey,” Clinical Infectious Diseases, vol. 40, no. 2, pp. 218–224, 2005. View at: Publisher Site | Google Scholar
  24. S. F. Costa, M. H. Miceli, and E. J. Anaissie, “Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?” The Lancet Infectious Diseases, vol. 4, no. 5, pp. 278–286, 2004. View at: Publisher Site | Google Scholar
  25. M. T. Brady, “Health care-associated infections in the neonatal intensive care unit,” American Journal of Infection Control, vol. 33, no. 5, pp. 268–275, 2005. View at: Publisher Site | Google Scholar
  26. U. A. Mireya, P. O. Martí, K. V. Xavier, L. O. Cristina, M. M. Miguel, and C. M. Magda, “Nosocomial infections in paediatric and neonatal intensive care units,” Journal of Infection, vol. 54, no. 3, pp. 212–220, 2007. View at: Publisher Site | Google Scholar
  27. D. Von Dolinger de Brito, H. de Almeida Silva, E. Jose Oliveira et al., “Effect of neonatal intensive care unit environment on the incidence of hospital-acquired infection in neonates,” Journal of Hospital Infection, vol. 65, no. 4, pp. 314–318, 2007. View at: Publisher Site | Google Scholar
  28. V. Shivanna, S. Sunkappa, and D. Venkatesha, “The rising trend of coagulase-negative staphylococci in neonatal septicemia,” Indian Journal of Pathology and Microbiology, vol. 59, no. 4, pp. 510–512, 2016. View at: Publisher Site | Google Scholar
  29. A. L. Shane and B. J. Stoll, “Neonatal sepsis: progress towards improved outcomes,” Journal of Infection, vol. 68, no. Suppl 1, pp. S24–S32, 2014. View at: Publisher Site | Google Scholar
  30. B. J. Stoll, N. Hansen, A. A. Fanaroff et al., “Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network,” Pediatrics, vol. 110, no. 2, pp. 285–291, 2002. View at: Publisher Site | Google Scholar
  31. D. A. Goldmann, “The bacterial flora of neonates in intensive care-monitoring and manipulation,” Journal of Hospital Infection, vol. 11, pp. 340–351, 1988. View at: Publisher Site | Google Scholar
  32. T. J. Foster, “Immune evasion by staphylococci,” Nature Reviews Microbiology, vol. 3, no. 12, pp. 948–958, 2005. View at: Publisher Site | Google Scholar
  33. J. Huebner and D. A. Goldmann, “Coagulase-negative staphylococci: role as pathogens,” Annual Review of Medicine, vol. 50, no. 1, pp. 223–236, 1999. View at: Publisher Site | Google Scholar
  34. C. Klingenberg, E. Aarag, A. Rønnestad et al., “Coagulase-negative staphylococcal sepsis in neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response,” The Pediatric Infectious Disease Journal, vol. 24, no. 9, pp. 817–822, 2005. View at: Publisher Site | Google Scholar
  35. Y. Qu, A. J. Daley, T. S. Istivan, S. M. Garland, and M. A. Deighton, “Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation,” Annals of Clinical Microbiology and Antimicrobials, vol. 9, no. 1, p. 16, 2010. View at: Publisher Site | Google Scholar
  36. S. Kocianova, C. Vuong, Y. Yao et al., “Key role of poly-γ-dl-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 688–694, 2005. View at: Publisher Site | Google Scholar
  37. E. A. Marchant, G. K. Boyce, M. Sadarangani, and P. M. Lavoie, “Neonatal sepsis due to coagulase-negative staphylococci,” Clinical and Developmental Immunology, vol. 2013, Article ID 586076, 10 pages, 2013. View at: Publisher Site | Google Scholar
  38. J. C. Madan, R. C. Salari, D. Saxena et al., “Gut microbial colonisation in premature neonates predicts neonatal sepsis,” Archives of Disease in Childhood—Fetal and Neonatal Edition, vol. 97, no. 6, pp. F456–F462, 2012. View at: Publisher Site | Google Scholar
  39. S. Basu, “Neonatal sepsis: the gut connection,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 34, no. 2, pp. 215–222, 2015. View at: Publisher Site | Google Scholar
  40. P. Das, A. K. Singh, T. Pal, S. Dasgupta, T. Ramamurthy, and S. Basu, “Colonization of the gut with gram-negative bacilli, its association with neonatal sepsis and its clinical relevance in a developing country,” Journal of Medical Microbiology, vol. 60, no. 11, pp. 1651–1660, 2011. View at: Publisher Site | Google Scholar
  41. Ü. Parm, T. Metsvaht, E. Sepp et al., “Mucosal surveillance cultures in predicting Gram-negative late-onset sepsis in neonatal intensive care units,” Journal of Hospital Infection, vol. 78, no. 4, pp. 327–332, 2011. View at: Publisher Site | Google Scholar
  42. R. Bradford, R. Abdul Manan, A. J. Daley et al., “Coagulase-negative staphylococci in very-low-birth-weight infants: inability of genetic markers to distinguish invasive strains from blood culture contaminants,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 25, no. 5, pp. 283–290, 2006. View at: Publisher Site | Google Scholar
  43. F. C. Tenover, R. D. Arbeit, R. V. Goering et al., “Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing,” Journal of Clinical Microbiology, vol. 33, no. 9, pp. 2233–2239, 1995. View at: Publisher Site | Google Scholar
  44. N. Shi, N. Li, X. Duan, and H. Niu, “Interaction between the gut microbiome and mucosal immune system,” Military Medical Research, vol. 4, no. 1, p. 14, 2017. View at: Publisher Site | Google Scholar
  45. S. Singh, B. Dhawan, A. Kapil et al., “Coagulase-negative staphylococci causing blood stream infection at an Indian tertiary care hospital: prevalence, antimicrobial resistance and molecular characterisation,” Indian Journal of Medical Microbiology, vol. 34, no. 4, pp. 500–505, 2016. View at: Publisher Site | Google Scholar

Copyright © 2020 Jennifer O. Adeghate et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.